PDYN and opioid use disorder: In conclusion, we propose that modulation of the dynorphin/KOR system is a promising target for addressing hyperalgesia and hyperkatifeia during opioid withdrawal, which could potentially be used for the treatment of opioid use disorder and addiction more generally.